A detailed history of Northern Trust Corp transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 41,504 shares of PRPH stock, worth $26,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,504
Previous 41,802 0.71%
Holding current value
$26,147
Previous $174,000 42.53%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.16 - $4.06 $643 - $1,209
-298 Reduced 0.71%
41,504 $100,000
Q2 2024

Aug 14, 2024

SELL
$4.18 - $7.35 $4,986 - $8,768
-1,193 Reduced 2.77%
41,802 $174,000
Q1 2024

May 14, 2024

SELL
$4.47 - $6.47 $13,262 - $19,196
-2,967 Reduced 6.46%
42,995 $278,000
Q4 2023

Feb 13, 2024

BUY
$4.35 - $5.1 $98,040 - $114,943
22,538 Added 96.22%
45,962 $207,000
Q3 2023

Nov 13, 2023

SELL
$4.23 - $7.53 $807 - $1,438
-191 Reduced 0.81%
23,424 $102,000
Q2 2023

Aug 11, 2023

SELL
$7.15 - $9.78 $500 - $684
-70 Reduced 0.3%
23,615 $171,000
Q1 2023

May 15, 2023

BUY
$6.62 - $9.57 $10,433 - $15,082
1,576 Added 7.13%
23,685 $180,000
Q3 2022

Nov 14, 2022

BUY
$8.96 - $14.7 $32,820 - $53,846
3,663 Added 19.86%
22,109 $249,000
Q2 2022

Aug 12, 2022

SELL
$6.52 - $13.24 $2,738 - $5,560
-420 Reduced 2.23%
18,446 $234,000
Q3 2021

Nov 15, 2021

SELL
$4.89 - $7.82 $4,811 - $7,694
-984 Reduced 4.96%
18,866 $98,000
Q2 2021

Aug 13, 2021

SELL
$4.61 - $6.83 $68,868 - $102,033
-14,939 Reduced 42.94%
19,850 $123,000
Q1 2021

May 12, 2021

SELL
$6.19 - $16.0 $72,342 - $186,992
-11,687 Reduced 25.15%
34,789 $257,000
Q4 2020

Feb 11, 2021

BUY
$3.9 - $11.25 $22,893 - $66,037
5,870 Added 14.46%
46,476 $426,000
Q3 2020

Nov 16, 2020

SELL
$1.4 - $3.87 $828 - $2,291
-592 Reduced 1.44%
40,606 $141,000
Q4 2019

Feb 14, 2020

SELL
$1.66 - $2.2 $13 - $17
-8 Reduced 0.02%
41,198 $81,000
Q1 2019

May 13, 2019

BUY
$2.7 - $3.65 $1,144 - $1,547
424 Added 1.04%
41,206 $124,000
Q4 2018

Feb 12, 2019

SELL
$2.95 - $3.27 $1,649 - $1,827
-559 Reduced 1.35%
40,782 $128,000
Q2 2018

Aug 14, 2018

SELL
$2.84 - $5.41 $9,389 - $17,885
-3,306 Reduced 7.4%
41,341 $134,000
Q1 2018

May 09, 2018

BUY
$2.24 - $3.21 $66,102 - $94,727
29,510 Added 194.95%
44,647 $132,000
Q4 2017

Feb 14, 2018

SELL
$2.05 - $2.3 $1,432 - $1,607
-699 Reduced 4.41%
15,137 $33,000
Q3 2017

Nov 13, 2017

BUY
$2.03 - $2.29 $32,147 - $36,264
15,836
15,836 $34,000

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $10.1M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.